Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms

Area of Science:

• Molecular Biology
• Biotechnology
• Infectious Disease Diagnostics

Background:

• Conventional SARS-CoV-2 RNA detection methods like real-time PCR and serological tests have limitations.
• There is a critical need for rapid, accurate, cost-effective, and sensitive diagnostic approaches for COVID-19.
• CRISPR-Cas13 systems offer a promising alternative for nucleic acid detection.

Purpose of the Study:

• To review technical advancements in CRISPR-Cas13-based diagnostic methods for SARS-CoV-2/COVID-19.
• To critically analyze the challenges and opportunities for implementing CRISPR-Cas13 platforms for mass testing.

Main Methods:

• Review of recent scientific literature on CRISPR-Cas13 applications in SARS-CoV-2 detection.
• Analysis of technical features, performance, and implementation potential of various CRISPR-Cas13 platforms.

Main Results:

• CRISPR-Cas13 systems have been successfully adapted for sensitive and specific detection of SARS-CoV-2 RNA.
• These methods offer advantages such as speed, simplicity, and potential for point-of-care use.
• Various CRISPR-Cas13 formats have been developed, demonstrating flexibility across different specimen types.

Conclusions:

• CRISPR-Cas13-based diagnostics represent a significant advancement in SARS-CoV-2 RNA detection.
• Further development and validation are needed to overcome challenges for widespread clinical implementation and mass testing.
• These novel platforms hold great potential for improving global COVID-19 diagnostic capabilities.